Rethinking Our COVID-19 Strategy
As of Feb 21, 2021, the COVID-19 pandemic claimed over half a million lives in the U.S., and over half of the country's population has likely had an infection. Our strategy to deal with the COVID-19 pandemic to date has been to rely very heavily on vaccination while testing and anti-viral devel...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Andover House Inc.
2021-03-01
|
| Series: | Precision Nanomedicine |
| Online Access: | https://prnano.scholasticahq.com/article/21569-rethinking-our-covid-19-strategy.pdf |